Latest Insider Transactions at Nu Skin Enterprises, Inc. (NUS)
This section provides a real-time view of insider transactions for Nu Skin Enterprises, Inc. (NUS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NU SKIN ENTERPRISES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NU SKIN ENTERPRISES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 18
2022
|
Joseph Y Chang Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,542
-21.98%
|
$261,680
$40.33 P/Share
|
Dec 18
2022
|
Joseph Y Chang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,800
+18.6%
|
$251,600
$37.58 P/Share
|
Dec 12
2022
|
Emma S. Battle Director |
BUY
Small Acquisition
|
Direct |
18
+0.23%
|
$738
$41.63 P/Share
|
Dec 07
2022
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.08%
|
$560
$40.98 P/Share
|
Nov 25
2022
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-16.93%
|
$950,000
$38.45 P/Share
|
Nov 25
2022
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+8.14%
|
$850,000
$34.11 P/Share
|
Nov 22
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.46%
|
$38,000
$38.16 P/Share
|
Oct 21
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.44%
|
$35,000
$35.92 P/Share
|
Sep 22
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.42%
|
$36,000
$36.67 P/Share
|
Sep 12
2022
|
Emma S. Battle Director |
BUY
Small Acquisition
|
Direct |
19
+0.25%
|
$722
$38.84 P/Share
|
Sep 07
2022
|
James D Thomas Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,602
-11.18%
|
$62,478
$39.19 P/Share
|
Sep 07
2022
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.09%
|
$585
$39.54 P/Share
|
Aug 25
2022
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-8.85%
|
$1,050,000
$42.99 P/Share
|
Aug 25
2022
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+8.13%
|
$850,000
$34.11 P/Share
|
Aug 22
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.4%
|
$45,000
$45.01 P/Share
|
Aug 18
2022
|
Steven Keith Hatchett Chief Product Officer |
SELL
Open market or private sale
|
Direct |
5,500
-10.01%
|
$253,000
$46.78 P/Share
|
Aug 01
2022
|
Chayce David Clark EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
137
-0.6%
|
$6,028
$44.56 P/Share
|
Jul 22
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.38%
|
$43,000
$43.0 P/Share
|
Jun 23
2022
|
Steven Lund Exec. Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
17,129
-10.2%
|
$770,805
$45.11 P/Share
|
Jun 22
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.36%
|
$44,000
$44.06 P/Share
|
Jun 22
2022
|
Steven Lund Exec. Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
800
-1.0%
|
$36,000
$45.01 P/Share
|
Jun 21
2022
|
Steven Lund Exec. Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
6,426
-7.2%
|
$289,170
$45.02 P/Share
|
Jun 17
2022
|
Steven Lund Exec. Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
900
-0.92%
|
$40,500
$45.01 P/Share
|
Jun 15
2022
|
Steven Lund Exec. Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
395
-0.44%
|
$17,775
$45.0 P/Share
|
Jun 13
2022
|
Emma S. Battle Director |
BUY
Small Acquisition
|
Direct |
15
+0.2%
|
$690
$46.38 P/Share
|
Jun 13
2022
|
Steven Lund Exec. Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
51,300
-13.77%
|
$2,257,200
$44.14 P/Share
|
Jun 08
2022
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
13
+0.08%
|
$598
$46.52 P/Share
|
Jun 06
2022
|
Mark H Lawrence Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,868
-10.85%
|
$275,796
$47.03 P/Share
|
Jun 05
2022
|
Steven Keith Hatchett Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
464
-0.84%
|
$21,344
$46.91 P/Share
|
Jun 05
2022
|
Chayce David Clark EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
649
-2.76%
|
$29,854
$46.91 P/Share
|
Jun 02
2022
|
Andrew D Lipman Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,179
+4.15%
|
-
|
Jun 02
2022
|
Laura Nathanson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,179
+20.76%
|
-
|
Jun 02
2022
|
Pisano R. Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,179
+5.32%
|
-
|
Jun 02
2022
|
Zheqing Shen Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,179
+15.27%
|
-
|
Jun 02
2022
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,179
+16.02%
|
-
|
Jun 02
2022
|
Emma S. Battle Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,179
+36.02%
|
-
|
Jun 02
2022
|
Daniel W Campbell Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,179
+17.79%
|
-
|
Jun 01
2022
|
Joseph Y Chang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
16,000
-23.23%
|
$736,000
$46.61 P/Share
|
Jun 01
2022
|
Joseph Y Chang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+29.11%
|
$480,000
$30.63 P/Share
|
May 25
2022
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-8.82%
|
$1,100,000
$44.84 P/Share
|
May 25
2022
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+8.13%
|
$850,000
$34.11 P/Share
|
May 23
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.4%
|
$44,000
$44.95 P/Share
|
May 18
2022
|
Steven Lund Exec. Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
925
-0.51%
|
$42,550
$46.07 P/Share
|
May 16
2022
|
Steven Lund Exec. Chairman of the Board |
SELL
Open market or private sale
|
Indirect |
21,200
-10.52%
|
$954,000
$45.25 P/Share
|
May 13
2022
|
Steven Lund Exec. Chairman of the Board |
SELL
Bona fide gift
|
Indirect |
14,935
-6.9%
|
-
|
Apr 22
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.38%
|
$47,000
$47.72 P/Share
|
Apr 21
2022
|
Connie Mang Yee Tang Chief Global Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,120
-3.41%
|
$52,640
$47.5 P/Share
|
Apr 21
2022
|
Connie Mang Yee Tang Chief Global Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,264
+13.83%
|
-
|
Mar 22
2022
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.37%
|
$47,000
$47.4 P/Share
|
Mar 09
2022
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.09%
|
$564
$47.9 P/Share
|